financetom
Business
financetom
/
Business
/
Insurance broker Aon beats profit estimates on strong business growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insurance broker Aon beats profit estimates on strong business growth
Nov 3, 2024 11:28 AM

Oct 25 (Reuters) - Aon beat Wall Street

estimates for third-quarter profit on Friday, driven by strong

growth in its commercial risk solutions business.

WHY IT'S IMPORTANT

A strong labor market and growing expectation of soft

landing of the U.S. economy have kept the demand for insurance

services intact across various sectors, despite higher costs.

That boosted the commission earned by insurance brokers as

their earnings are tied to the premiums charged by insurers.

BY THE NUMBERS

Adjusted net income attributable to Aon shareholders rose to

$594 million, or $2.72 per share, in the three months ended

Sept. 30, from $474 million, or $2.32 per share, a year ago.

Analysts on average estimated an adjusted profit of $2.48

per share, according to data compiled by LSEG.

Revenue of the broker from its commercial risk solutions

unit jumped 17% to $1.85 billion in the quarter.

Aon's health solutions unit's revenue rose to $870 million,

compared with $552 million in the year-ago quarter.

CONTEXT

Aon provides advice and services on risk management through

four principal products - commercial risk, reinsurance, health

solutions and wealth solutions.

Last week, its peer Marsh McLennan ( MMC ) also reported a

rise in third-quarter profit on insurance unit strength.

(Reporting by Prakhar Srivastava in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved